asian lady.png

On The Mend
Transform physical rehab for everyone

Pre-register for early access to our crowdfunding campaign and join us on our mission to improve the experience and outcomes for everyone involved with physical rehab.

Capital at Risk. Approved by


Pre-register to invest

On The Mend is building a digital platform with the goal of improving how healthcare is delivered to millions of people around the world. We now want our customers, suppliers, friends and family to own a piece of the company and join us on our mission.

We will soon be launching a crowdfunding campaign to give you the unique opportunity to help shape this future vision. When the campaign opens, you will be able to support us in exchange for shares in our company.

If you are interested in joining us on this exciting journey, please enter your email address along with a non-committal indication of the level of support you are considering giving us, and we will keep you updated on the progress of our campaign. By pre-registering, you will also be given priority access when the campaign goes live.

Follow this link to pre-register at

Capital at Risk.

Cog 1 copy_0_edited.png
Cog 1_0_edited.png
Cog 1 copy 2_0_edited.png

Why are we crowdfunding?

We are ready to start piloting our digital platform in a range of healthcare settings, from private clinics to NHS trusts and community physiotherapists. We will continue work with healthcare provider and payer organisations to demonstrate a positive impact on patient health outcomes and the experience of everyone involved with physical rehab.

Cog 1 copy_0_edited.png
Cog 1 copy_0_edited.png
Cog 1 copy 2_0_edited.png

Achieving product market fit

We will use this funding round to support our efforts at successfully completing early usability and acceptance testing with patients and their healthcare professionals in a range of clinical settings. We believe this will put us in a strong position to start generating early revenues with other healthcare providers, some of whom we have been in active discussions since our pre-product phase. We will look to support efforts at commercialising our platform with further independent studies aimed at demonstrating clinical validity as well as seeking to further develop early inroads into overseas markets.


Continuous product improvement

We will incorporate invaluable feedback from pilot studies into our product pipeline, ensuring we deliver a platform that adds value by meeting the needs of our customers. Working with our software development partners, we will continue to develop and test a range of new and innovative product features that will result in an industry-leading user experience and meaningful improvements in patient outcomes.


Growing our team

We will use part of this funding round to grow our headcount in supporting the successful delivery of our pilots. We are always looking to further expand our team by adding talented people who believe in our mission and will continue to add advisors and NEDs who can support us in executing our

go-to-market strategy.


Why Join Our Campaign?

Because our passionate team is committed to growing our brand and building an industry-leading physical rehab tech platform, and we’d love you to be a part of our journey.


We have ambitious goals for the business and would love for you to come on board with us. We are asking you to

pre-register if you are interested so we can let you know first when we launch our campaign. This comes at no obligation to you, you can change your mind at any time.

Pre-register now by completing the form above.

If there's anything we can help you with regarding our crowdfunding campaign before you pre-register, or if you'd like us to send you more information, please contact us here: [email protected].

Capital at Risk.

Investing involves risks, including loss of capital, illiquidity, lack of dividends and dilution, and should be done only as part of a diversified portfolio. This page has been approved as a financial promotion by Seedrs Limited, which is authorised and regulated by the Financial Conduct Authority (No. 550317).